Vasan Ramachandran is baffled. A cardiologist and veteran of the famed Framingham Heart Study, he is struggling to understand why a similar study he brought to life in 10 rural counties across four Southern states is facing elimination. The Rural Cohort Study, set in motion six years ago, was nearing its recruitment goal of 3,300 people, a sign that it was winning the trust of people in remote areas of Alabama, Mississippi, Louisiana and Kentucky.
Participants don’t walk into a brick-and-mortar building for this study. The research team travels to them, working in a mobile examination unit housed in a 50-foot trailer weighing about 50,000 metric tons and carrying a CT scanner plus a cardiac ultrasound machine that uses AI. “We take the science to the people,” he said.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.